Your browser is no longer supported. Please, upgrade your browser.
PACB [NASD]
Pacific Biosciences of California, Inc.
Index- P/E643.47 EPS (ttm)0.05 Insider Own1.20% Shs Outstand186.16M Perf Week-1.96%
Market Cap6.34B Forward P/E- EPS next Y-0.74 Insider Trans-70.89% Shs Float180.45M Perf Month-9.47%
Income29.40M PEG- EPS next Q-0.46 Inst Own99.20% Short Float7.14% Perf Quarter-16.41%
Sales78.90M P/S80.40 EPS this Y130.50% Inst Trans8.49% Short Ratio2.87 Perf Half Y125.86%
Book/sh1.80 P/B17.52 EPS next Y27.50% ROA10.10% Target Price51.50 Perf Year979.79%
Cash/sh1.58 P/C19.90 EPS next 5Y-1.00% ROE20.80% 52W Range2.79 - 53.69 Perf YTD21.55%
Dividend- P/FCF342.89 EPS past 5Y19.10% ROI8.20% 52W High-41.27% Beta1.16
Dividend %- Quick Ratio8.90 Sales past 5Y-3.20% Gross Margin41.30% 52W Low1030.11% ATR2.80
Employees412 Current Ratio9.20 Sales Q/Q-2.90% Oper. Margin35.00% RSI (14)46.82 Volatility6.72% 8.58%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin37.30% Rel Volume0.49 Prev Close32.85
ShortableYes LT Debt/Eq0.00 EarningsApr 29 AMC Payout0.00% Avg Volume4.48M Price31.53
Recom2.40 SMA20-2.54% SMA50-9.88% SMA20060.62% Volume2,176,510 Change-4.02%
Feb-11-21Upgrade Piper Sandler Neutral → Overweight $20 → $52
Nov-03-20Downgrade Piper Sandler Overweight → Neutral $12
Oct-02-20Upgrade JP Morgan Neutral → Overweight $15
Sep-09-20Initiated Morgan Stanley Equal-Weight $7
Jun-02-20Resumed Cantor Fitzgerald Overweight $5
Mar-09-20Resumed Cantor Fitzgerald Overweight $5
Oct-15-19Upgrade Piper Jaffray Neutral → Overweight $8
Apr-02-19Downgrade Stephens Overweight → Equal-Weight $4.50 → $8
Oct-19-18Initiated Cowen Outperform
Nov-03-17Downgrade First Analysis Sec Overweight → Equal-Weight $4
Sep-28-17Downgrade CL King Buy → Neutral
Nov-03-16Reiterated Cantor Fitzgerald Buy $18 → $15
Jun-27-16Initiated CL King Buy
Apr-15-16Initiated First Analysis Sec Overweight $11
Feb-04-16Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16Reiterated Cantor Fitzgerald Buy $11 → $18
Oct-23-15Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Initiated Cantor Fitzgerald Buy
Feb-04-15Reiterated Maxim Group Buy $10 → $11
Sep-26-13Reiterated Maxim Group Buy $4 → $8
Apr-15-21 04:05PM  
Apr-11-21 10:26AM  
Mar-25-21 10:46AM  
Mar-16-21 12:51PM  
Mar-12-21 11:30AM  
Mar-02-21 04:30PM  
Feb-26-21 04:04PM  
Feb-24-21 08:00AM  
Feb-19-21 09:50AM  
Feb-18-21 08:01AM  
Feb-12-21 12:08AM  
Feb-11-21 12:24PM  
08:24AM  
06:00AM  
Feb-10-21 09:31PM  
07:41PM  
07:30PM  
05:15PM  
04:24PM  
04:02PM  
02:30PM  
12:26PM  
10:28AM  
08:45AM  
08:44AM  
08:41AM  
08:00AM  
05:20AM  
Feb-09-21 10:23AM  
09:29AM  
Feb-05-21 05:00PM  
Feb-02-21 12:24PM  
06:12AM  
Jan-29-21 04:15PM  
Jan-27-21 02:30PM  
Jan-26-21 11:05AM  
Jan-20-21 11:36AM  
Jan-13-21 12:19PM  
11:15AM  
08:02AM  
Jan-12-21 06:26PM  
Jan-11-21 07:45AM  
Jan-08-21 03:16PM  
08:45AM  
08:00AM  
Jan-07-21 09:13AM  
Jan-01-21 01:31AM  
Dec-31-20 05:00AM  
Dec-24-20 11:10AM  
Dec-23-20 07:29PM  
08:37AM  
Dec-18-20 04:05PM  
Dec-16-20 08:00AM  
Dec-14-20 08:00AM  
Dec-10-20 10:02AM  
Dec-09-20 12:04PM  
Dec-03-20 12:36PM  
12:15PM  
Dec-02-20 11:30AM  
Nov-11-20 12:21AM  
Nov-10-20 04:05PM  
Nov-04-20 08:39AM  
Nov-03-20 06:15AM  
05:19AM  
04:02AM  
Nov-02-20 06:15PM  
04:46PM  
04:02PM  
02:30PM  
Oct-30-20 12:51PM  
Oct-26-20 12:31PM  
Oct-22-20 08:00AM  
Oct-19-20 12:30PM  
Oct-15-20 08:00AM  
Oct-08-20 11:30AM  
Oct-06-20 07:44PM  
Oct-05-20 08:00AM  
Oct-02-20 03:37PM  
12:00PM  
Sep-23-20 08:59AM  
Sep-22-20 07:13AM  
Sep-16-20 11:55AM  
Sep-14-20 09:00AM  
Sep-09-20 09:44AM  
Sep-02-20 11:30AM  
Aug-18-20 08:43AM  
Aug-12-20 12:51PM  
Aug-11-20 11:20PM  
04:32PM  
Aug-10-20 01:02PM  
Aug-07-20 08:30AM  
Aug-04-20 08:14AM  
06:40AM  
02:01AM  
Aug-03-20 06:35PM  
04:02PM  
08:05AM  
08:00AM  
Aug-02-20 11:08AM  
Jul-27-20 12:31PM  
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hunkapiller MichaelDirectorFeb 26Option Exercise6.36234,2461,490,2071,082,651Mar 02 08:31 PM
Hunkapiller MichaelDirectorFeb 26Sale31.02234,2467,265,866848,405Mar 02 08:31 PM
Hunkapiller MichaelDirectorFeb 25Option Exercise6.40339,3772,172,2911,187,782Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 25Sale32.33339,37710,972,944848,405Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 24Option Exercise6.05266,4271,613,0961,114,832Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 24Sale36.80266,4279,805,281848,405Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 23Option Exercise5.97373,3212,227,8491,221,726Feb 24 08:50 PM
Hunkapiller MichaelDirectorFeb 23Sale34.88373,32113,022,317848,405Feb 24 08:50 PM
Hunkapiller MichaelDirectorFeb 22Option Exercise5.53229,1271,266,2511,077,532Feb 24 08:50 PM
Schaefer EricChief Accounting OfficerFeb 22Sale39.203,842150,60688,474Feb 24 08:21 PM
Hunkapiller MichaelDirectorFeb 22Sale39.14229,1278,967,407848,405Feb 24 08:50 PM
ORDONEZ KATHYDirectorFeb 16Option Exercise4.92185,879915,243242,646Feb 18 09:52 PM
ORDONEZ KATHYDirectorFeb 16Sale47.99220,77110,595,81021,875Feb 18 09:52 PM
Botstein DavidDirectorFeb 12Option Exercise4.42160,000706,800160,000Feb 17 09:15 PM
LIVINGSTON RANDALL SDirectorFeb 12Option Exercise4.3667,500294,40067,500Feb 17 09:17 PM
Shapiro LucyDirectorFeb 12Sale50.40101,6665,123,9660Feb 17 09:19 PM
LIVINGSTON RANDALL SDirectorFeb 12Sale48.0767,5003,244,4550Feb 17 09:17 PM
Botstein DavidDirectorFeb 12Sale49.62160,0007,939,7640Feb 17 09:15 PM
Hunkapiller MichaelDirectorJan 25Option Exercise6.14125,406769,993973,811Jan 27 05:07 PM
Hunkapiller MichaelDirectorJan 25Sale36.34125,4064,556,901848,405Jan 27 05:07 PM
Hunkapiller MichaelDirectorJan 22Option Exercise6.14150,857926,262999,262Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 22Sale36.77150,8575,547,490848,405Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 21Option Exercise3.31208,711691,4111,106,926Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 21Sale36.58258,5219,457,071848,405Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 20Option Exercise2.27215,026488,1091,113,241Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 20Sale39.19215,0268,426,269898,215Jan 22 09:49 PM
Hunkapiller MichaelDirectorDec 22Option Exercise3.01364,4511,096,9981,262,666Dec 23 06:34 PM
Hunkapiller MichaelDirectorDec 22Sale25.62364,4519,335,716898,215Dec 23 06:34 PM
Hunkapiller MichaelDirectorDec 21Option Exercise2.88335,549965,8771,233,764Dec 23 06:34 PM
Hunkapiller MichaelDirectorDec 21Sale23.00335,5497,718,327898,215Dec 23 06:34 PM
Hunkapiller MichaelDirectorNov 24Sale14.381,49221,4620Nov 25 04:46 PM
Hunkapiller MichaelDirectorNov 23Sale15.03251,8373,785,6141,492Nov 24 04:44 PM
Hunkapiller MichaelDirectorNov 20Sale15.11147,7992,233,538253,329Nov 24 04:44 PM
Hunkapiller MichaelDirectorNov 19Sale15.552,20134,226401,128Nov 20 05:16 PM
Hunkapiller MichaelDirectorNov 18Sale15.7138,381603,004403,329Nov 20 05:16 PM
Hunkapiller MichaelDirectorNov 16Sale15.8942,488675,347441,710Nov 18 04:05 PM
Hunkapiller MichaelDirectorNov 12Sale16.73200,0003,345,800484,198Nov 13 05:17 PM
Hunkapiller MichaelDirectorNov 11Sale16.46250,0004,116,000684,198Nov 13 05:17 PM
Hunkapiller MichaelDirectorNov 11Sale14.25195,6522,788,041898,215Nov 13 05:17 PM
Hunkapiller MichaelDirectorNov 10Sale14.251,304,34818,586,9591,093,867Nov 13 05:17 PM
Hunkapiller MichaelCEO & PresidentAug 25Sale6.44228,6321,472,619934,198Aug 26 05:08 PM
MILLIGAN JOHN FDirectorAug 24Option Exercise3.32110,000365,200110,000Aug 26 07:29 PM
Hunkapiller MichaelCEO & PresidentAug 24Sale6.63259,1641,719,4751,162,830Aug 26 05:08 PM
Hunkapiller MichaelCEO & PresidentAug 21Sale6.57189,8471,246,9151,421,994Aug 24 06:04 PM
Hunkapiller MichaelCEO & PresidentAug 20Sale6.47256,5541,659,8021,611,841Aug 24 06:04 PM